CA3191653A1 - Mepyramine for use in the topical treatment of neuropathic pain - Google Patents

Mepyramine for use in the topical treatment of neuropathic pain

Info

Publication number
CA3191653A1
CA3191653A1 CA3191653A CA3191653A CA3191653A1 CA 3191653 A1 CA3191653 A1 CA 3191653A1 CA 3191653 A CA3191653 A CA 3191653A CA 3191653 A CA3191653 A CA 3191653A CA 3191653 A1 CA3191653 A1 CA 3191653A1
Authority
CA
Canada
Prior art keywords
topical composition
neuropathy
mepyramine
neuropathic pain
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3191653A
Other languages
English (en)
French (fr)
Inventor
Celine Greco
Patrick Delmas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Assistance Publique - Hôpitaux de Paris
Original Assignee
Centre National de la Recherche Scientifique
Assistance Publique - Hôpitaux de Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique, Assistance Publique - Hôpitaux de Paris filed Critical Centre National de la Recherche Scientifique
Publication of CA3191653A1 publication Critical patent/CA3191653A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA3191653A 2020-09-11 2021-09-10 Mepyramine for use in the topical treatment of neuropathic pain Pending CA3191653A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306009.0 2020-09-11
EP20306009.0A EP3967308A1 (en) 2020-09-11 2020-09-11 Mepyramine for use in the topical treatment of neuropathic pain
PCT/EP2021/074906 WO2022053598A1 (en) 2020-09-11 2021-09-10 Mepyramine for use in the topical treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
CA3191653A1 true CA3191653A1 (en) 2022-03-17

Family

ID=72615785

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3191653A Pending CA3191653A1 (en) 2020-09-11 2021-09-10 Mepyramine for use in the topical treatment of neuropathic pain

Country Status (7)

Country Link
US (1) US20230321059A1 (cg-RX-API-DMAC7.html)
EP (2) EP3967308A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023540355A (cg-RX-API-DMAC7.html)
KR (1) KR20230083272A (cg-RX-API-DMAC7.html)
AU (1) AU2021342331A1 (cg-RX-API-DMAC7.html)
CA (1) CA3191653A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022053598A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026119772A1 (fr) 2024-12-02 2026-06-11 Assistance Publique Hopitaux De Paris Nanoparticules de mepyramine et de squalene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521342D0 (en) * 1985-08-27 1985-10-02 Univ Glasgow Medicament
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain

Also Published As

Publication number Publication date
US20230321059A1 (en) 2023-10-12
WO2022053598A1 (en) 2022-03-17
JP2023540355A (ja) 2023-09-22
EP3967308A1 (en) 2022-03-16
KR20230083272A (ko) 2023-06-09
EP4210699A1 (en) 2023-07-19
AU2021342331A1 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
DE602004007225T2 (de) Methode zur behandlung von erkrankungen der unteren harnwege
ES2812532T3 (es) Compuestos, formulaciones y procedimientos para tratar o prevenir la rosácea
JP4970685B2 (ja) 眼痛の処置方法
US20100184817A1 (en) Methods of treating neuropathy
JP2010537988A (ja) 紅斑を治療するための改良ブリモニジン組成物
KR20190004815A (ko) 안과 치료제
CN101977605A (zh) 雷诺嗪治疗疼痛的用途
EP3551166B1 (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
AU2002310788B2 (en) Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
DE60315258T2 (de) Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals
JP2024012412A (ja) 局所と局部の麻酔と鎮痛
KR20010021854A (ko) 말초 작용성 항소양성 아편제
US20230321059A1 (en) Mepyramine for use in the topical treatment of neuropathic pain
US9187468B2 (en) Topical ocular analgesic agents
KR20250004041A (ko) 삼차 신경통 치료 및 그와 관련된 통증 감소에 사용하기 위한 트리메프라진
SK7832000A3 (en) New use of local anaesthetics against vascular headaches
US20070105940A1 (en) Method for treating pain
US20080255238A1 (en) Composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
JP2000515865A (ja) 過剰攻撃を処置する方法
WO2006087481A1 (fr) Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2
HK40015081A (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240904

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240904

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240904

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260225

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260226

B12 Application deemed to be withdrawn, abandoned or lapsed

Free format text: ST27 STATUS EVENT CODE: N-6-6-B10-B12-B301 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO A REQUEST FOR EXAMINATION NOTICE

Effective date: 20260427

U13 Renewal or maintenance fee not paid

Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE

Effective date: 20260427

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260709